Single and Multiple Ascending Dose Study of CORT125329 in Healthy Participants
Status:
Recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the dose-related safety, tolerability,
pharmacokinetics (PK) and pharmacological effects (PD) of CORT125329 after single and
multiple ascending oral doses of CORT125329 lipid capsule formulations in healthy
participants.